DE2328972A1 - N-alkyl-benzoyl aminobenzylamines - by direct alkylation antitussives - Google Patents
N-alkyl-benzoyl aminobenzylamines - by direct alkylation antitussivesInfo
- Publication number
- DE2328972A1 DE2328972A1 DE2328972A DE2328972A DE2328972A1 DE 2328972 A1 DE2328972 A1 DE 2328972A1 DE 2328972 A DE2328972 A DE 2328972A DE 2328972 A DE2328972 A DE 2328972A DE 2328972 A1 DE2328972 A1 DE 2328972A1
- Authority
- DE
- Germany
- Prior art keywords
- general formula
- reaction
- carried out
- methyl
- radical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Case 5/597 Dr. Fl./Kp/ Case 5/597 Dr. Fl./Kp/
DR. KARL THOMAE GMEH., BIBERACH AN DER RISS DR.KARL THOMAE GMEH., BIBERACH AN DER RISS
Neues Verfahren zur Herstellung von 2 - A cy lami no-ben ?,y I r. r ι '\ η e ηNew method for the production of 2 - A cy lami no- ben ?, Y I r. r ι '\ η e η
Das britische Patent 1 Ο98 140 beschreibt u. a. P-Acylaminc-bensylamine der allgemeinen Formel I,British patent 1 98140 describes, inter alia, P-acylamine-bensylamine of the general formula I,
in derin the
R den Morpholino- oder Isopropylaminorest bedeuten, deren physiologisch verträgliche Salze mit anorganischen und organischen Säuren und Verfahren zu ihrer Herstellung.R denotes the morpholino or isopropylamino radical, their physiologically tolerable salts with inorganic and organic acids and processes for their preparation.
Die Verbindungen der obigen allgemeinen Formel I besitzen wertvolle pharmakologische Eigenschaften, insbesondere hustenstillende und atemanregende Wirkungen. Überraschenderweise wurde nunThe compounds of the above general formula I have valuable pharmacological properties, in particular antitussive and breath-stimulating effects. Surprisingly it was now
409881/1251409881/1251
festgestellt, daß die Verbindungen der obigen allgemeinen Fcrrr.ol I sich auch nach folgendem Verfahren herstellen lassen: found that the compounds of the above general formula I can also be prepared by the following process:
Umsetzung einer Verbindung der allgemeinen Formel ITjImplementation of a compound of the general formula ITj
^ H ^ H
CIL,
Hal _JT 7Γ ^™ „ Cö._ K2 (ΙΪ} CIL,
Hal _JT 7Γ ^ ™ "Coe ._ K 2 (ΙΪ}
MtT Γ'MtT Γ '
KH - COKH - CO
in derin the
R und Kai wie eingangs definiert sind, reit einer Verbindung der allgemeinen Formel III,R and Kai are as defined at the outset, riding a compound of the general formula III,
R1-X (III)R 1 -X (III)
in derin the
R wie eingangs definiert ist undR is as defined at the outset and
X ein Chlor-, Brom- oder Jodatom oder einen Rest der Formel -0-SOpR,, wobei R., zweckmäßigerweise die Methyl- oder M-Methylphenylgruppe darstellt, bedeutet.X is a chlorine, bromine or iodine atom or a radical of the formula -0-SOpR ,, where R., expediently represents the methyl or M-methylphenyl group.
Die Umsetzung wird vorzugsweise in einem inerten Lösungsmittel wie Aceton, Methanol, Dioxan oder Tetrahydrofuran, gegebenenfalls in Gegenwart einer Base wie Natriumhydroxid, Kaliumhydroxid oder Kalium-tert.-butylat, zweckmäßigerweise bei Temperaturen zwischen 0°C und der Siedetemperatur des verwendeten Lösungsmittels durchgeführt, beispielsweise bei Temperaturen zwischen 20 und 80°C.The reaction is preferably carried out in an inert solvent such as acetone, methanol, dioxane or tetrahydrofuran, optionally in the presence of a base such as sodium hydroxide, potassium hydroxide or potassium tert. butoxide, expediently carried out at temperatures between 0 ° C and the boiling point of the solvent used, for example at temperatures between 20 and 80 ° C.
Eine Methylierung kann auch durch Erhitzen, z.B. auf Temperaturen zwischen 80 und 100°C, mit Formaldehyd und Ameisensäure durchge- Methylation can also be carried out by heating, for example to temperatures between 80 and 100 ° C, with formaldehyde and formic acid .
409881/1251409881/1251
führt werden.leads to be.
Das Verfahren der vorliegenden Anmeldung konnte nicht vorhergesehen v/erden, da aus der Literatur bekannt ist, daß man bei der Alkylierung von Aminen kein einheitliches Reaktionsprodukt erhält. So erhält man beispielsweise bei der Alkylierung von sekundären Aninon unter Verwendung eines Überschusses des entsprechenden Alkylier'J.ngsmittels immer ein Gemisch des entsprechenden tertiären Amins und der entsprechenden quartären Ammoniumverbindung (siehe beispielsweise Fieser f< Fieser in Organic Chemistry. Seite 229, Verlag Reinhold Publishing Corporation 1956 und Houben-V.'eyl V\_/l, Seite 2'O. Beim Erhitzen von o-Acylaniino-benzylaminen mit Säuren erhält man normalerweise 3,i<-Dihydro-chiriazoline und bei der Umsetzung mit Formaldehyd entstehen 1,2 ,3 ,^-Tetrahydro-chir.uzoli ne (ε-iehe beispielsweise A. V/eisseriberger in Chemistry of Heterocyclic Compounds 2j[/I, .Seiten 395 und MO] (1967)),The process of the present application could not have been foreseen since it is known from the literature that a uniform reaction product is not obtained in the alkylation of amines. For example, in the alkylation of secondary aninones using an excess of the corresponding alkylating agent, a mixture of the corresponding tertiary amine and the corresponding quaternary ammonium compound is always obtained (see, for example, Fieser and Fieser in Organic Chemistry. Page 229, Verlag Reinhold Publishing Corporation 1956 and Houben-V.'eyl V \ _ / l , page 2'O. When o-acylaniino-benzylamines are heated with acids, normally 3, i <-dihydro-chiriazolines are obtained and when reacting with formaldehyde 1, 2, 3, ^ - Tetrahydro-chir.uzoli ne (ε-iehe for example A. V / eisseriberger in Chemistry of Heterocyclic Compounds 2j [/ I,. Pages 395 and MO] (1967)),
Die erhaltenen Verbindungen der allgemeinen Formel 1 können gewünschtenfalls anschließend in ihre physiologisch vertraglichen Salze mit anorganischen oder organischen Sä υπ.-η übergeführt wer-ier:.' Als Säuren haben sich hierbei Salzsäure > Hrov-A.-asserst of fsäure, Schwefelsäure, Phosphorsäure, Milchsäure, Zitronensäure oder Maleinsäure als geeignet erwiesen.The compounds of general formula 1 obtained can, if desired then converted into their physiologically compatible salts with inorganic or organic acids. The acids here have proven to be hydrochloric acid> Hrov-A.-asteroic acid, Sulfuric acid, phosphoric acid, lactic acid, citric acid or maleic acid proved suitable.
Die als Ausgangsstoffe verwendeten Verbindungen der allgemeinen Formel II erhält man beispielsweise durch Umsetzung des entsprechenden Benzylhalogenids mit den entsprechenden Glycinderivat (siehe beispielsweise britisches Patent 1 098 1*JO) .The compounds used as starting materials of the general Formula II is obtained, for example, by reacting the corresponding benzyl halide with the corresponding glycine derivative (see e.g. British patent 1 098 1 * JO).
Die nachfolgenden Beispiele sollen die Erfindung näher erläutern:The following examples are intended to explain the invention in more detail:
409881 / 1251409881/1251
BAD QRiGiMALBATHROOM QRiGiMAL
2-Benzoylamino-6-chlor-N-methyl-N-(morpholino-carbonyl-methyl)-benzylamin 2-Benzoylamino-6-chloro-N-methyl-N- (morpholino-carbonyl-methyl) -benzylamine
0,42 g (0,001 Mol) 2-Benzoylamino-6-chlor-N-(morpholino-carbonylmethyl)-benzylamin-hydrochlorid und 0,11 g (0,002 MoI) Kaliumhydroxid werden in 20 ml Aceton gelöst und bei Raumtemperatur 0,28 g (0,002 Mol) Methyljodid hinzugefügt. Das Reaktionsgemisch wird 15 Stunden bei Raumtemperatur stehen gelassen, dann werden die ausgefallenen Salze abgesaugt und mit Aceton gewaschen. Die Aceton-LÖ-sung wird eingedampft, der Eindampfrückstand in Essigester aufgenommen, mit Wasser gewaschen, über Magnesiumsulfat getrocknet und im Vakuum eingedampft. Der Rückstand ergibt nach Kristallisation aus Äther 0,25 g (62,2 % der Theorie) 2-Benzoylamino-6-chlor-N-methyl-N-(morpholino-carbonyl-!7iethyl)-benzylamin von Schmelzpunkt 122,5 - 123°C.0.42 g (0.001 mol) of 2-benzoylamino-6-chloro-N- (morpholino-carbonylmethyl) -benzylamine hydrochloride and 0.11 g (0.002 mol) of potassium hydroxide are dissolved in 20 ml of acetone and 0.28 g at room temperature (0.002 mol) methyl iodide added. The reaction mixture is left to stand for 15 hours at room temperature, then the precipitated salts are filtered off with suction and washed with acetone. The acetone solution is evaporated, the evaporation residue is taken up in ethyl acetate, washed with water, dried over magnesium sulfate and evaporated in vacuo. After crystallization from ether, the residue yields 0.25 g (62.2 % of theory) of 2-benzoylamino-6-chloro-N-methyl-N- (morpholino-carbonyl-! 7iethyl) -benzylamine with a melting point of 122.5-123 ° C.
2-Benzoylamino-6-chlor-N-isopropyl-N-(morpholino-carbonyl-methyl)-benzylamin 2-Benzoylamino-6-chloro-N-isopropyl-N- (morpholino-carbonyl-methyl) -benzylamine
Schmelzpunkt: 125 - 127°CMelting point: 125-127 ° C
Hergestellt aus 2-Benzoylamino-6-chlor-N-(morpholino-carbonyltnethyU-benzylamin-hydrochlorid, Isopropyljodid und Kaliumhydroxid analog Beispiel 1.Made from 2-benzoylamino-6-chloro-N- (morpholino-carbonyltnethyU-benzylamine hydrochloride, Isopropyl iodide and potassium hydroxide analogous to Example 1.
2-Benzoylamino-4-chlor-N-methyl-N-(isopropylamino-carbonyl-methyl)· benzylamin 2-Benzoylamino-4-chloro-N-methyl-N- (isopropylamino-carbonyl-methyl) benzylamine
409881/1251 bad oni3„ML 409881/1251 bad o ni3 " ML
Schmelzpunkt des Hydrochlorids: I89 - 193°C (Zers.). Hergestellt aus 2-Benzoylamino-4-chlor-N-(isopropy1amino-carbonylmethyl)-benzylamin, Methyljodid und Kaliumhydroxid analog Beispiel 1.Melting point of the hydrochloride: 189-193 ° C (decomp.). Made from 2-benzoylamino-4-chloro-N- (isopropy1amino-carbonylmethyl) -benzylamine, Methyl iodide and potassium hydroxide as in Example 1.
2-Benzoylamino-6-chlor-N-methyl-N-(morpholino-carbonyl-methyl)-benzylamin 2-Benzoylamino-6-chloro-N-methyl-N- (morpholino-carbonyl-methyl) -benzylamine
2,12 g (0,0055 Mol) 2-Benzoylamino-6-chlor-N-(morpholino-carbonylmethyD-benzylamin (Schmelzpunkt: l6l-l63°C), 5 ml (0,012 Mol) 98%ige Ameisensäure und 0,55 ml (0,0055 Mol) 30%ige v;äßrige Formaldehyd-Lösung werden 6 Stunden auf dem Dampfbad erhitzt. Man bringt im Vakuum zur Trockne, löst den Rückstand in V/asser und dampft erneut ein. Nach abermaligem Lösen in Wasser bringt man mit 2n Ammoniak auf pH 9 und extrahiert das ausgefallene öl mit Essigester. Der organische Extrakt wird mit Wasser gewaschen, über Magnesiumsulfat getrocknet und im Vakuum eingedampft. Der Rückstand wird mit Äther kristallisiert, abgesaugt und mit Äther gewaschen. Man erhält l>50 g (67 % der Theorie) der oben genannten Verbindung mit einem Schmelzpunkt von 122,5 - 123°C.2.12 g (0.0055 mol) of 2-benzoylamino-6-chloro-N- (morpholino-carbonylmethyl-benzylamine (melting point: 16-163 ° C), 5 ml (0.012 mol) of 98% formic acid and 0.55 ml (0.0055 mol) of 30% strength aqueous formaldehyde solution are heated on the steam bath for 6 hours, brought to dryness in vacuo, the residue dissolved in water and evaporated again with 2N ammonia to pH 9 and the precipitated oil is extracted with ethyl acetate. The organic extract is washed with water, dried over magnesium sulfate and evaporated in vacuo. The residue is crystallized with ether, filtered off with suction and washed with ether. 1> 50 g ( 67 % of theory) of the abovementioned compound with a melting point of 122.5-123 ° C.
2-Benzoylamino-6-chlor-N-methyl-N-(morpholino-carbonyl-methyl)-benzylamin 2-Benzoylamino-6-chloro-N-methyl-N- (morpholino-carbonyl-methyl) -benzylamine
1,25 g (0,0032 Mol) 2-Benzoylamino-6-chlor-N-(morpholino-carbonylmethyD-benzylamin (Schmelzpunkt: I6I - l63°C) und 0,6 g (0,00322 Mol) p-Toluolsulfonsäure-methylester werden in 30 ml Methanol 6 Stunden unter Rückfluß gekocht. Nach Abdampfen des Methanols im Vakuum wird der Rückstand in Essigester aufgenommen, und die erhaltene Lösung wird mit Wasser und 2n Ammoniak gewaschen. Die getrocknete Lösung (Magnesiumsulfat) wird im Vakuum zur Trockne ein-1.25 g (0.0032 moles) of 2-benzoylamino-6-chloro-N- (morpholino-carbonylmethyl-benzylamine (Melting point: 160-163 ° C.) and 0.6 g (0.00322 mol) of methyl p-toluenesulfonate are dissolved in 30 ml of methanol 6 Boiled under reflux for hours. After evaporation of the methanol in vacuo, the residue is taken up in ethyl acetate, and the resulting Solution is washed with water and 2N ammonia. The dried solution (magnesium sulfate) is brought to dryness in a vacuum.
409881/1251409881/1251
geengt. Den verbleibenden Rückstand reinigt man durch Chromatographie über eine Kieselgelsäule mit Essigester. Die gewünschten Fraktionen·'"werden im Vakuum eingeengt und das erhaltene öl mit Äther kristallisiert. Man erhält 0,42 g (31 % der Theorie) der oben genannten Substanz vom Schmelzpunkt 122,5 - 123°C.narrowed. The remaining residue is purified by chromatography on a silica gel column with ethyl acetate. The desired fractions are concentrated in vacuo and the oil obtained is crystallized with ether. 0.42 g (31 % of theory) of the abovementioned substance with a melting point of 122.5-123 ° C. is obtained.
2-Benzoylamino-6-brom-N-methyl-N-(morpholine-carbonyl-methyl)-benzylamin 2-Benzoylamino-6-bromo-N-methyl-N- (morpholine-carbonyl-methyl) -benzylamine
Schmelzpunkt: 159 - l6l°C.Melting point: 159-161 ° C.
Hergestellt aus 2-Benzoylamino-6-brom-N-(morpholino-carbonylmethyD-benzylamin und Formaldehyd/Ameisensäure analog BeispielMade from 2-benzoylamino-6-bromo-N- (morpholino-carbonylmethyD-benzylamine and formaldehyde / formic acid analogous to the example
409881/1251409881/1251
Claims (5)
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2328972A DE2328972A1 (en) | 1973-06-07 | 1973-06-07 | N-alkyl-benzoyl aminobenzylamines - by direct alkylation antitussives |
AT350974A AT333294B (en) | 1973-06-07 | 1974-04-29 | NEW PROCESS FOR THE PRODUCTION OF 2-ACYLAMINOBENZYLAMINES |
ES426120A ES426120A1 (en) | 1973-06-07 | 1974-05-09 | Procedure for the preparation of 2-acilamino-bencilaminas. (Machine-translation by Google Translate, not legally binding) |
FI1440/74A FI144074A (en) | 1973-06-07 | 1974-05-10 | |
YU01424/74A YU36369B (en) | 1973-06-07 | 1974-05-22 | New process for preparing 2-acilamino-benzylamines |
NL7407063A NL7407063A (en) | 1973-06-07 | 1974-05-27 | |
BG026806A BG21853A3 (en) | 1973-06-07 | 1974-05-28 | METHOD FOR PREPARING 2-ACYLAMINO-BENZYLAMINE |
DK300774A DK300774A (en) | 1973-06-07 | 1974-06-04 | |
HUTO963A HU167682B (en) | 1973-06-07 | 1974-06-05 | |
CA201,832A CA1050543A (en) | 1973-06-07 | 1974-06-06 | Process for the preparation of 2-acylamino-benzylamines |
MX575074U MX4070E (en) | 1973-06-07 | 1974-06-06 | PROCEDURE FOR THE PREPARATION OF 2-ACILAMINO-BENCILAMINAS |
JP6451674A JPS5735706B2 (en) | 1973-06-07 | 1974-06-06 | |
SE7407487A SE409857B (en) | 1973-06-07 | 1974-06-06 | PROCEDURE FOR THE PREPARATION OF 2-ACYLAMINOBENZYLAMINES |
PL1974171701A PL89956B1 (en) | 1973-06-07 | 1974-06-06 | |
CH785174A CH599127A5 (en) | 1973-06-07 | 1974-06-07 | |
AT768575A AT333295B (en) | 1973-06-07 | 1975-10-08 | NEW PROCESS FOR THE PRODUCTION OF 2-ACYLAMINO-BENZYLAMINES AND THEIR SALT |
YU00613/81A YU61381A (en) | 1973-06-07 | 1981-03-10 | New process for preparing 2-acylamino-benzylamines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2328972A DE2328972A1 (en) | 1973-06-07 | 1973-06-07 | N-alkyl-benzoyl aminobenzylamines - by direct alkylation antitussives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2328972A1 true DE2328972A1 (en) | 1975-01-02 |
Family
ID=5883287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2328972A Pending DE2328972A1 (en) | 1973-06-07 | 1973-06-07 | N-alkyl-benzoyl aminobenzylamines - by direct alkylation antitussives |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS5735706B2 (en) |
AT (1) | AT333294B (en) |
BG (1) | BG21853A3 (en) |
CA (1) | CA1050543A (en) |
CH (1) | CH599127A5 (en) |
DE (1) | DE2328972A1 (en) |
DK (1) | DK300774A (en) |
ES (1) | ES426120A1 (en) |
FI (1) | FI144074A (en) |
HU (1) | HU167682B (en) |
NL (1) | NL7407063A (en) |
PL (1) | PL89956B1 (en) |
SE (1) | SE409857B (en) |
YU (2) | YU36369B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6013224U (en) * | 1983-07-05 | 1985-01-29 | 東京濾器株式会社 | air cleaner |
-
1973
- 1973-06-07 DE DE2328972A patent/DE2328972A1/en active Pending
-
1974
- 1974-04-29 AT AT350974A patent/AT333294B/en not_active IP Right Cessation
- 1974-05-09 ES ES426120A patent/ES426120A1/en not_active Expired
- 1974-05-10 FI FI1440/74A patent/FI144074A/fi unknown
- 1974-05-22 YU YU01424/74A patent/YU36369B/en unknown
- 1974-05-27 NL NL7407063A patent/NL7407063A/xx not_active Application Discontinuation
- 1974-05-28 BG BG026806A patent/BG21853A3/en unknown
- 1974-06-04 DK DK300774A patent/DK300774A/da not_active Application Discontinuation
- 1974-06-05 HU HUTO963A patent/HU167682B/hu unknown
- 1974-06-06 CA CA201,832A patent/CA1050543A/en not_active Expired
- 1974-06-06 JP JP6451674A patent/JPS5735706B2/ja not_active Expired
- 1974-06-06 PL PL1974171701A patent/PL89956B1/pl unknown
- 1974-06-06 SE SE7407487A patent/SE409857B/en unknown
- 1974-06-07 CH CH785174A patent/CH599127A5/xx not_active IP Right Cessation
-
1981
- 1981-03-10 YU YU00613/81A patent/YU61381A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPS5032141A (en) | 1975-03-28 |
ATA350974A (en) | 1976-03-15 |
SE7407487L (en) | 1974-12-09 |
JPS5735706B2 (en) | 1982-07-30 |
DK300774A (en) | 1975-02-03 |
CA1050543A (en) | 1979-03-13 |
ES426120A1 (en) | 1976-07-01 |
CH599127A5 (en) | 1978-05-12 |
BG21853A3 (en) | 1976-09-20 |
YU36369B (en) | 1983-06-30 |
PL89956B1 (en) | 1976-12-31 |
NL7407063A (en) | 1974-12-10 |
SE409857B (en) | 1979-09-10 |
HU167682B (en) | 1975-11-28 |
FI144074A (en) | 1974-12-08 |
YU142474A (en) | 1981-11-13 |
YU61381A (en) | 1983-09-30 |
AT333294B (en) | 1976-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2265370C2 (en) | 6-phenyl-1,2,3,4-tetrahydro-1,5-benzodiazocine derivatives | |
DE1795808B1 (en) | Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine | |
EP0155335A1 (en) | Process for the preparation of 3,5-dimethoxy-4-alkoxy-benzaldehydes | |
DE2328972A1 (en) | N-alkyl-benzoyl aminobenzylamines - by direct alkylation antitussives | |
DE2931735A1 (en) | NEW SUBSTITUTED PHENYLACETYLGUANIDINE AND METHOD FOR THE PRODUCTION THEREOF | |
DE69016857T2 (en) | Process for the preparation of NiNi-diakyl-1,8-naphthalenediamine. | |
DE2618756C3 (en) | 2-phenyl-4,5-di- (hydroxyinethyl) imidazole compounds and processes for their preparation | |
DE2165109A1 (en) | Process for the preparation of alpha-methyl-beta- (3,4-dihydroxyphenyl) -alanine | |
DE2814355C3 (en) | Process for the preparation of 4-methyl-5 - [(2-aminoethyl) thiomethyl] imidazole dihydrochloride | |
EP0222205B1 (en) | Process for the preparation of imidazolyl-methane derivatives | |
DE1301321B (en) | Process for the preparation of imidazo [2, 1-b] thiazole derivatives | |
DE1926076B2 (en) | 3- (3-Amino-2-hydroxy-propyl) -6.7> 8trimethoxy-SH-M ^ -benzotriazin ^ -one derivatives and their preparation | |
DE3403778A1 (en) | CYANOMETHYL- (2-CYANO-ETHYL) - (3-HYDROXY-PROPYL) -AMINE HIS USE FOR PRODUCING 1- (3-HYDROXY-PROPYL) -1,4-DIAZEPANE AND 1,4-BIS (3- (3rd , 4,5-TRIMETHOXYBENZOYLOXY) -PROPYL) -DIAZEPAN | |
CH411847A (en) | Process for the production of camphor derivatives | |
DE2400658A1 (en) | p-Acetamidophenoxypropanolamine derivs. - with beta-adrenergic blocking activity | |
DE2311637C3 (en) | Process for the preparation of 2-aminobenzylamines | |
DE2223193C3 (en) | Process for the preparation of 2-amino-benzylamines | |
AT333295B (en) | NEW PROCESS FOR THE PRODUCTION OF 2-ACYLAMINO-BENZYLAMINES AND THEIR SALT | |
DE1018869B (en) | Process for the preparation of aminoalkyl purine derivatives | |
DE2337455A1 (en) | Pure 2-amino-3,5-dibromo-benzylamine prepn - by reacting 2-acylamino-3,5-dibromobenzylalcohol with N-methyl cyclohexylamine in presence of base | |
AT234691B (en) | Process for the preparation of new piperidine derivatives | |
DE2338409A1 (en) | 2-Aminobenzylamine derivs prepn. - by direct amination of 2-aminobenzyl derivs, used as secretolytics and anti-tussives | |
DE2052840A1 (en) | 1-(2-(chloro)-phenyl)-5-substd -8-chloro-2,34,5-tetrahydro - 1,5-benzo-1h-diazepin-2-ones-as sedatives, anti convulsants and muscl | |
DE3320138A1 (en) | NEW NORTROPINE DERIVATIVE, METHOD FOR THE PRODUCTION AND USE THEREOF | |
CH500199A (en) | 2-substd-1 3-diazacyclopentene 2 derivs hypotensives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OHJ | Non-payment of the annual fee |